Skip to main content

Table 7 Missed interventions for prevention and control of NCDs in Iran

From: Assessment and prioritization of the WHO “best buys” and other recommended interventions for the prevention and control of non-communicable diseases in Iran

Objective

Missed interventions

Type of intervention

1

1.3 Strengthen international cooperation for resource mobilization, capacity-building, health workforce training and exchange of information on lessons learned and best practices

Overarching/enabling policy interventions.

2

2.2 Assess national capacity for prevention and control of NCDs

4

4.2 Explore viable health financing mechanisms and innovative economic tools supported by evidence

4

4.7 Develop and implement a palliative care policy, including access to opioids analgesics for pain relief, together with training for health workers

3

3.38 Limiting portion and package size to reduce energy intake and the risk of overweight/obesity

Other recommended interventions from WHO guidance (cost-effective analysis not available).

3

3.45 Ensure that macro-level urban design incorporates the core elements of residential density, connected street networks that include sidewalks, easy access to a diversity of destinations and access to public transport

4

4.16 Anticoagulation for medium-and high-risk non-valvular atrial fibrillation and for mitral stenosis with atrial fibrillation

4

4.31 Oral cancer screening in high-risk groups (for example, tobacco users, betel-nut chewers) linked with timely treatment

4

4.10 Treatment of new cases of acute myocardial infarction** with either: acetylsalicylic acid, or acetylsalicylic acid and clopidogrel, or thrombolysis, or primary percutaneous coronary interventions (PCI)

Effective interventions with cost-effectiveness analysis >I$ 100 per DALY averted in LMICs.

4

4.12 Primary prevention of rheumatic fever and rheumatic heart diseases by increasing appropriate treatment of streptococcal pharyngitis at the primary care level

4

4.13 Secondary prevention of rheumatic fever and rheumatic heart disease by developing a register of patients who receive regular prophylactic penicillin

4

4.26 Vaccination against human papillomavirus (2 doses) of 9–13-year-old girls

‘Best buys’: Effective interventions with cost-effectiveness analysis = I$ 100 per DALY averted in LMICs.